Rapid Oral Fluid Screening Devices Market To Register Exponential Compound Annual Growth Rate Through 2022 – 2031 : Fact.MR

Worldwide sales of rapid oral fluid screening devices are estimated to surpass 17,700 thousand units in 2019, up from nearly 16,500 units in 2018. The growing demand for of rapid oral fluid screening devices can be attributed to the ever-augmenting cases of drug abuse and alcoholism in many countries across the globe. Tougher regulations and mandates for drug and alcohol testing continue to induce momentum in this market.

The study finds that efficacy of oral fluid for drug testing is being widely acknowledged on account of accuracy and precision of results. Multiple applications, such as pain management, drug treatment, and DUID (driving under influence of drugs) or drug-impaired driving, entail use of rapid oral fluid screening devices for instant yet accurate results. In addition, increasing number of hospital-based laboratories and independent laboratories are making use of rapid oral fluid screening devices to perform multimodal tests.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=2694

As per the research study, oral fluid serves as a viable medium for drug testing, on account of the convenience to collect and low risks of sample adulteration. Results obtained via oral fluid offer better understanding of the impact of drug abuse and seamless evaluation of an individual’s behavioral changes. As per the report, shorter window of time will continue being a key growth inhibitor of rapid oral fluid screening devices market. Drugs ingested in less than around 24 hours and cannabis ingested in less than around 4 hours are effectively detected by these devices, which makes them a misfit in case of challenging and prolonged screening sessions. This, in turn, is likely to pose significant challenges for the manufacturers in the rapid oral fluid screening devices market.

Prescription drug abuse i.e. the intentional usage of medications without prescriptions is emerging as a serious concern across the globe that can lead to devastating results. The practice of prescription drug abuse rising at alarming rates and subsequent number of deaths in consequence of drug overdose is resulting in ever-increasing number of emergency room visits, which, in turn, is likely to significantly contribute to growth of rapid oral fluid screening devices market.

Rapid Oral Fluid Screening Devices Market – Key Growth Drivers

  • Alcoholism and drug abuse is increasing at an alarming rate in many countries across the globe. This, in turn, has resulted into high focus on drug and alcohol testing, thereby creating sustained opportunities for manufacturers and other stakeholders.
  • Growing use of rapid oral fluid screening devices by physician laboratories, independent laboratories, and hospital-based laboratories to perform diagnostic procedures.
  • Oral fluid is being widely recognized as a reliable medium to diagnose the ripple effects of drug abuse. Oral samples are convenient in terms of collection with no specific requirement and have minimum risk of adulteration, thereby fuelling investments in rapid oral fluid screening devices market.
  • Prescription drug abuse, wherein medications are consumed without a physician’s supervision or prescription, has become a serious issue leading to serious health-related adversities. Increasing cases of prescription drug abuse are foreseen to provide impetus to growth of rapid oral fluid screening devices market.
  • In line with the evolving business models in healthcare landscape, development of effective and scalable products is on a significant rise, followed by favorable reimbursements. This, in turn, is estimated to create revenue-generating opportunities for the key stakeholders in rapid oral fluid screening devices market.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=2694

End-Users Prefer Strips as Ideal Rapid Oral Fluid Screening Devices over Swabs and Cassettes

According to the research study, end-users are likely to opt for strips over swabs and cassettes, with global sales anticipated to exceed 11,400 thousand units in 2019. Easy-to-carry with minimum inconvenience involved makes strip a feasible option as compared to other forms of rapid oral fluid screening devices. In addition, strips are highly cost-effective as compared to swabs and cassettes, which makes it a viable investment for end-users who value frugality. As per the report, Europe and North America represent are likely to brim with opportunities for the key players of rapid oral fluid screening devices market, on account of the highest rates of illicit drug usage.

One of the pervasive trends favoring the growth of rapid oral fluid screening devices market is the ever- growing trend of workplace drug testing. More and more number of employers are conducting oral fluid testing sessions for post-accident, pre-employment, and randomized drug tests using rapid oral fluid screening devices. This process of drug test results in multiple financial and practical benefits, providing enough credence to its importance in dynamic workplaces.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/2694

The research report by Fact.MR offers incisive insights into the forecast analysis of rapid oral fluid screening devices market. As per the report, the rapid oral fluid screening devices market is estimated to grow at a value CAGR of over 7% during the forecast period. 

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Related Articles

Back to top button